These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35186388)

  • 1. Clinical and Laboratory Profile of Gangliosidosis from Southern Part of India.
    Gowda VK; Gupta P; Bharathi NK; Bhat M; Shivappa SK; Benakappa N
    J Pediatr Genet; 2022 Mar; 11(1):34-41. PubMed ID: 35186388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): Diagnosis and Neuroimaging Findings (An Iranian Pediatric Case Series).
    Karimzadeh P; Jafari N; Nejad Biglari H; Jabbeh Dari S; Ahmad Abadi F; Alaee MR; Nemati H; Saket S; Tonekaboni SH; Taghdiri MM; Ghofrani M
    Iran J Child Neurol; 2014; 8(3):55-60. PubMed ID: 25143775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1 and GM2-Gangliosidosis: Clinical Features, Neuroimaging Findings and Electroencephalography.
    Karimzadeh P; Ebrahimi M; Etemad K; Ahmad Abadi F; Hosseini Nezhad Z
    Iran J Child Neurol; 2024; 18(2):127-140. PubMed ID: 38617391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM2 gangliosidosis AB variant: novel mutation from India - a case report with a review.
    Sheth J; Datar C; Mistri M; Bhavsar R; Sheth F; Shah K
    BMC Pediatr; 2016 Jul; 16():88. PubMed ID: 27402091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
    Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
    Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset.
    Kern J; Böhringer J; Timmann D; Trollmann R; Stendel C; Kamm C; Röbl M; Santhanakumaran V; Groeschel S; Beck-Wödl S; Göricke S; Krägeloh-Mann I; Synofzik M
    Neurology; 2024 Jan; 102(1):e207898. PubMed ID: 38165373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
    Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
    Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gangliosidoses.
    Patterson MC
    Handb Clin Neurol; 2013; 113():1707-8. PubMed ID: 23622392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible biomarker of neurocytolysis in infantile gangliosidoses: aspartate transaminase.
    Kılıç M; Kasapkara ÇS; Kılavuz S; Mungan NÖ; Biberoğlu G
    Metab Brain Dis; 2019 Apr; 34(2):495-503. PubMed ID: 30712135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses.
    Hall P; Minnich S; Teigen C; Raymond K
    Curr Protoc Hum Genet; 2014 Oct; 83():17.16.1-8. PubMed ID: 25271840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
    Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile gangliosidoses: Mapping a timeline of clinical changes.
    Jarnes Utz JR; Kim S; King K; Ziegler R; Schema L; Redtree ES; Whitley CB
    Mol Genet Metab; 2017 Jun; 121(2):170-179. PubMed ID: 28476546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.
    Kobayashi T; Goto I; Okada S; Orii T; Ohno K; Nakano T
    J Neurochem; 1992 Oct; 59(4):1452-8. PubMed ID: 1402895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical juvenile presentation of G
    Martins C; Brunel-Guitton C; Lortie A; Gauvin F; Morales CR; Mitchell GA; Pshezhetsky AV
    Mol Genet Metab Rep; 2017 Jun; 11():24-29. PubMed ID: 28417072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitotriosidase as a biomarker for gangliosidoses.
    Kim S; Whitley CB; Jarnes JR
    Mol Genet Metab Rep; 2021 Dec; 29():100803. PubMed ID: 34646735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients.
    Welford RWD; Farine H; Steiner M; Garzotti M; Dobrenis K; Sievers C; Strasser DS; Amraoui Y; Groenen PMA; Giugliani R; Mengel E
    Mol Genet Metab Rep; 2022 Mar; 30():100843. PubMed ID: 35242574
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.